WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
HK Stock Market Move | DUALITYBIO-B(09606) soars over 6% with expectations for intensive readout of clinical data in 2026.
New Stock News | it is reported that the stock issuance for Muyuan Foods (002714.SZ) will start as early as Thursday with an estimated fundraising scale of approximately 1.5 billion US dollars.
New stock news | Leading company in heat-shrinkable materials and communication cables, Shenzhen Woer Heat-shrinkable Material (002130.SZ), passes the hearing at the Hong Kong Stock Exchange.
HK Stock Market Move | DUALITYBIO-B(09606) soars over 6% with expectations for intensive readout of clinical data in 2026.
New Stock News | it is reported that the stock issuance for Muyuan Foods (002714.SZ) will start as early as Thursday with an estimated fundraising scale of approximately 1.5 billion US dollars.
New stock news | Leading company in heat-shrinkable materials and communication cables, Shenzhen Woer Heat-shrinkable Material (002130.SZ), passes the hearing at the Hong Kong Stock Exchange.
RECOMMEND
New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026
117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026
“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026
